Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 230 participants.

Also called NCT01741922

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 230 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01741922
Other papers using this trial's data
  • Evaluation of the antihypertensive effect of nocturnal administration of acetylsalicylic acid: a cross-over randomized clinical trial Journal of hypertension, 2019-02 DOI, PubMed 30095728

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01741922. Randomized; triple masking; primary purpose treatment. Start 2012-12 (actual); primary completion 2015-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients
Acronym
TAHPS
Condition
Hypertension
Intervention (Drug)
ASA evening
Intervention (Drug)
Acetylsalicylic morning
Intervention (Drug)
Placebos morning
Intervention (Drug)
Placebo evening
Lead sponsor
Basque Health Service (class: other government)
Collaborator
Preventive Services and Health Promotion Research Network (class: other)
Collaborator
Spanish Clinical Research Network - SCReN (class: research network)
Collaborator
Public Health Service of Cataluña (class: other)

Record details

Record id
cardio:ct-nct01741922
Content hash
de48bf95a6bdbde9b4937c7788951caa0dba61017be20276f8fc3f4afecbfbaa